InsideHer News https://insideher.org Women's health news, reported with evidence. UNICEF opens a femtech funding call offering up to US$100,000 https://insideher.org/news/unicef-femtech-venture-fund-call-november-2026.html https://insideher.org/news/unicef-femtech-venture-fund-call-november-2026.html Thu, 15 Oct 2026 06:00:00 GMT Applications close on 4 November 2026; a functional prototype, eligible country registration and a commitment to open source are central requirements. Midi expands virtual care for UTIs, bacterial vaginosis and yeast infections https://insideher.org/news/midi-acute-uti-bv-yeast-infection-care.html https://insideher.org/news/midi-acute-uti-bv-yeast-infection-care.html Thu, 15 Oct 2026 06:00:00 GMT The new service combines acute appointments with follow-up when recurring symptoms need further assessment. Collective X raises $3.2M to put women’s health evidence behind digital products https://insideher.org/news/collective-x-womens-health-evidence-platform-funding.html https://insideher.org/news/collective-x-womens-health-evidence-platform-funding.html Thu, 15 Oct 2026 06:00:00 GMT Co-founded by Stacy Sims, the platform licenses female-specific research intelligence to health and performance companies through an API. Allara raises $30M to expand integrated, insurance-covered women’s healthcare https://insideher.org/news/allara-30m-insurance-covered-integrated-care.html https://insideher.org/news/allara-30m-insurance-covered-integrated-care.html Thu, 15 Oct 2026 06:00:00 GMT The virtual-care company plans to expand clinical technology, partnerships and research across hormonal, metabolic and reproductive health. A 300-million-test study maps changes across the body at menopause https://insideher.org/news/menopause-laboratory-study-physiological-transition.html https://insideher.org/news/menopause-laboratory-study-physiological-transition.html Thu, 15 Oct 2026 06:00:00 GMT A Nature Medicine analysis maps changes around the final menstrual period; independent experts caution against reading its “cliff” metaphor as inevitable decline. Gates Foundation and Wellcome Leap commit $100M to stillbirth prevention https://insideher.org/news/uzima-100m-stillbirth-prevention-programme.html https://insideher.org/news/uzima-100m-stillbirth-prevention-programme.html Thu, 15 Oct 2026 06:00:00 GMT The Uzima programme will test and scale promising approaches, starting with partners in sub-Saharan Africa. A large cohort study documents first endometriosis diagnoses after menopause https://insideher.org/news/endometriosis-first-diagnosis-after-menopause-study.html https://insideher.org/news/endometriosis-first-diagnosis-after-menopause-study.html Thu, 15 Oct 2026 06:00:00 GMT The Nurses’ Health Study II analysis challenges a narrow age-based picture of the disease, while distinguishing diagnosis from disease onset. Google and Flo put cycle data closer to everyday health tracking https://insideher.org/news/google-flo-womens-health-partnership.html https://insideher.org/news/google-flo-womens-health-partnership.html Tue, 13 Oct 2026 06:00:00 GMT The partnership will bring Flo’s reproductive-health expertise into Google’s women’s-health features, with privacy controls central to the rollout. WHO opens a portal to include pregnant and lactating women in trials https://insideher.org/news/who-pregnant-lactating-clinical-trials-portal.html https://insideher.org/news/who-pregnant-lactating-clinical-trials-portal.html Tue, 13 Oct 2026 06:00:00 GMT The WHO/HRP portal is meant to help researchers make inclusion the default earlier, not an afterthought once evidence gaps appear. FDA creates a class II path for home-collected molecular STI tests https://insideher.org/news/fda-home-collected-sti-molecular-tests-class-ii.html https://insideher.org/news/fda-home-collected-sti-molecular-tests-class-ii.html Tue, 13 Oct 2026 06:00:00 GMT The classification gives molecular tests using home-collected specimens a special-controls pathway rather than treating each product as a one-off. A huge maternal flu study narrows what can be inferred about child neuropsychiatric risk https://insideher.org/news/maternal-influenza-pregnancy-offspring-neuropsychiatric-study.html https://insideher.org/news/maternal-influenza-pregnancy-offspring-neuropsychiatric-study.html Tue, 13 Oct 2026 06:00:00 GMT The JAMA Network Open cohort found a modest population-level association that was attenuated in sibling comparisons. Pregnancy complications may flag later heart, diabetes and kidney risk https://insideher.org/news/pregnancy-complications-cardiometabolic-renal-risk.html https://insideher.org/news/pregnancy-complications-cardiometabolic-renal-risk.html Tue, 13 Oct 2026 06:00:00 GMT A BMJ Medicine study of 1.4 million women in England links several pregnancy complications with later cardiometabolic and renal diagnoses. A large vaginal-microbiome study links recent BV and UTIs to shared bacterial patterns https://insideher.org/news/vaginal-microbiome-bv-uti-metagenomics.html https://insideher.org/news/vaginal-microbiome-bv-uti-metagenomics.html Tue, 13 Oct 2026 06:00:00 GMT Nature Communications metagenomic data connect recent bacterial vaginosis and urinary tract infections with shifts in vaginal microbes and uropathogens. Healthy Moms, Healthy Babies America puts $20M into two state maternal-health bets https://insideher.org/news/hmhba-arkansas-kentucky-maternal-health-grants.html https://insideher.org/news/hmhba-arkansas-kentucky-maternal-health-grants.html Tue, 13 Oct 2026 06:00:00 GMT The first state grants send $10 million each to Arkansas and Kentucky as the initiative tries to scale proven maternal-care models. Biotia raises $9M to expand metagenomic testing for complicated UTIs https://insideher.org/news/biotia-uti-diagnostics-financing.html https://insideher.org/news/biotia-uti-diagnostics-financing.html Tue, 13 Oct 2026 06:00:00 GMT The company says the financing will expand access to its BIOTIA-ID Urine Test and support additional women’s-health diagnostics. Flouria reaches €1.5M to grow a women’s hormonal-health clinic https://insideher.org/news/flouria-hormonal-health-funding.html https://insideher.org/news/flouria-hormonal-health-funding.html Tue, 13 Oct 2026 06:00:00 GMT Healthy.Capital’s investment brings Flouria’s total funding to €1.5 million for growth in the Netherlands and future European expansion. WHO asks how AI is actually being used in family planning https://insideher.org/news/who-ai-family-planning-programmes.html https://insideher.org/news/who-ai-family-planning-programmes.html Fri, 09 Oct 2026 06:00:00 GMT The scoping review seeks practice-based evidence from governments, civil society and implementers, not only peer-reviewed papers. WHO sets a 2035 roadmap for hypertension in pregnancy https://insideher.org/news/who-pregnancy-hypertension-roadmap-2035.html https://insideher.org/news/who-pregnancy-hypertension-roadmap-2035.html Fri, 09 Oct 2026 06:00:00 GMT The global plan connects research, clinical standards, medicines, diagnostics and health-system delivery across the next decade. A 6.1M-person pain study gives women’s pain a global benchmark https://insideher.org/news/global-pain-reference-curves-sex-differences.html https://insideher.org/news/global-pain-reference-curves-sex-differences.html Tue, 06 Oct 2026 06:00:00 GMT Nature Medicine reference curves show women reported higher pain prevalence than men across all 11 anatomical sites studied. WHO says violence is shaping adolescent girls’ health before adulthood https://insideher.org/news/who-adolescent-girls-violence-analysis.html https://insideher.org/news/who-adolescent-girls-violence-analysis.html Tue, 06 Oct 2026 06:00:00 GMT A new analysis estimates about 43 million girls aged 15–19 have experienced intimate-partner violence, non-partner sexual violence, or both. Fetal DNA biology may be the next prenatal-testing frontier https://insideher.org/news/fetal-dna-prenatal-testing-nipt-review.html https://insideher.org/news/fetal-dna-prenatal-testing-nipt-review.html Sat, 03 Oct 2026 06:00:00 GMT A Science Advances review argues NIPT technology has outpaced knowledge of how fetal DNA circulates in maternal blood. Recurrent BV may have two different paths back https://insideher.org/news/bacterial-vaginosis-reinfection-persistence.html https://insideher.org/news/bacterial-vaginosis-reinfection-persistence.html Fri, 02 Oct 2026 06:00:00 GMT A Lancet women’s-health study points to reinfection and persistent BV bacteria, while researchers test more tailored treatment strategies. GLP-1 pregnancy evidence looks reassuring, but still thin https://insideher.org/news/glp-1-pregnancy-diabetes-evidence-gap.html https://insideher.org/news/glp-1-pregnancy-diabetes-evidence-gap.html Wed, 30 Sep 2026 06:00:00 GMT A Lancet review found no clear signal of major harm in most women with diabetes, while experts warned against reading that as proof of safety. FDA gives Lynkuet priority review for breast-cancer-treatment hot flashes https://insideher.org/news/fda-lynkuet-breast-cancer-hot-flash-priority-review.html https://insideher.org/news/fda-lynkuet-breast-cancer-hot-flash-priority-review.html Tue, 29 Sep 2026 06:00:00 GMT The supplemental application concerns vasomotor symptoms linked to endocrine therapy; priority review shortens the review goal but is not approval. WHO is revisiting how hyperglycaemia in pregnancy is diagnosed https://insideher.org/news/who-hyperglycaemia-pregnancy-guideline-update.html https://insideher.org/news/who-hyperglycaemia-pregnancy-guideline-update.html Sat, 26 Sep 2026 06:00:00 GMT A guideline group will review evidence on screening, diagnosis and classification later this month. Absci sketches a 2027 Phase 2 trial for its AI-designed endometriosis antibody https://insideher.org/news/absci-abs-201-endometriosis-phase-2-plan.html https://insideher.org/news/absci-abs-201-endometriosis-phase-2-plan.html Fri, 25 Sep 2026 06:00:00 GMT The proposed STORYLINE study would test ABS-201 in about 150 participants, subject to protocol finalization and regulatory clearance. WHO expands contraception guidance and maps a path for male methods https://insideher.org/news/who-expanded-contraception-options.html https://insideher.org/news/who-expanded-contraception-options.html Thu, 24 Sep 2026 06:00:00 GMT The update adds longer-use options for some existing methods and WHO’s first target product profile for new male contraceptives. Teal Health raises $22M to scale at-home HPV screening https://insideher.org/news/teal-health-series-a-at-home-hpv-screening.html https://insideher.org/news/teal-health-series-a-at-home-hpv-screening.html Wed, 23 Sep 2026 06:00:00 GMT The company says the Series A will expand payer, health-system and employer access before broader insurance coverage begins in 2027. EndoFusion shows how AI could shorten endometriosis diagnosis https://insideher.org/news/endofusion-ai-endometriosis-diagnosis.html https://insideher.org/news/endofusion-ai-endometriosis-diagnosis.html Thu, 17 Sep 2026 06:00:00 GMT The early framework combined MRI and ultrasound learning to detect signs of advanced disease, but it is not ready to replace clinical validation. NIH puts $21M behind digital twins for hormone biology https://insideher.org/news/nih-hormone-digital-twins-initiative.html https://insideher.org/news/nih-hormone-digital-twins-initiative.html Tue, 15 Sep 2026 06:00:00 GMT Six awards will build computational models from human data to study how hormones change across people, tissues and life stages. Samsung launches AI ultrasound tools for fibroids and high-risk pregnancy https://insideher.org/news/samsung-hera-z10-womens-health-ultrasound.html https://insideher.org/news/samsung-hera-z10-womens-health-ultrasound.html Tue, 08 Sep 2026 06:00:00 GMT The HERA Z10 combines automated fibroid mapping, three-dimensional microvascular imaging and workflow features for obstetric and gynecologic scans. Reproductive healthtech is scaling faster than its evidence https://insideher.org/news/reproductive-healthtech-evidence-gap.html https://insideher.org/news/reproductive-healthtech-evidence-gap.html Wed, 02 Sep 2026 06:00:00 GMT A UCL commentary argues that apps, wearables, at-home tests and telehealth need stronger clinical validation and clearer integration into care. ProFound receives up to $35M for AI-enabled pre-eclampsia discovery https://insideher.org/news/profound-preeclampsia-ai-funding.html https://insideher.org/news/profound-preeclampsia-ai-funding.html Fri, 28 Aug 2026 06:00:00 GMT The Gates Foundation-backed program will search for proteins, biomarkers and therapeutic targets; it is discovery funding, not a treatment milestone. AbCellera reports hot-flash reductions after one dose of ABCL635 https://insideher.org/news/abcellera-abcl635-menopause-phase-2.html https://insideher.org/news/abcellera-abcl635-menopause-phase-2.html Tue, 11 Aug 2026 06:00:00 GMT Company-reported Phase 2 results in 92 postmenopausal participants support further study, but are not yet a regulatory decision or peer-reviewed confirmation. A three-million-record study links endometriosis with higher diabetes risk https://insideher.org/news/endometriosis-type-2-diabetes-association.html https://insideher.org/news/endometriosis-type-2-diabetes-association.html Fri, 07 Aug 2026 06:00:00 GMT The retrospective analysis found an association with type 2 diabetes, particularly before menopause, but cannot show that endometriosis causes diabetes. NIH puts women’s-health innovation infrastructure in one place https://insideher.org/news/nih-womens-health-innovation-pipeline.html https://insideher.org/news/nih-womens-health-innovation-pipeline.html Tue, 04 Aug 2026 06:00:00 GMT A refreshed federal hub brings together small-business funding, data resources and research programs spanning the female life course. EMAS proposes a precision-and-digital model for menopause care https://insideher.org/news/emas-healthy-menopause-2026-framework.html https://insideher.org/news/emas-healthy-menopause-2026-framework.html Tue, 21 Jul 2026 06:00:00 GMT The 2026 framework combines prevention, personalized treatment, digital monitoring and cross-specialty care—but it is a position statement, not a clinical trial. FDA authorizes a first-of-its-kind contained gynecologic morcellation system https://insideher.org/news/fda-claria-contained-morcellation-system.html https://insideher.org/news/fda-claria-contained-morcellation-system.html Fri, 03 Jul 2026 06:00:00 GMT The Claria System received De Novo authorization for contained tissue reduction during laparoscopic hysterectomy in a limited patient population. Australia expands all 33 endometriosis clinics into menopause care https://insideher.org/news/australia-menopause-care-endometriosis-clinics.html https://insideher.org/news/australia-menopause-care-endometriosis-clinics.html Sat, 27 Jun 2026 06:00:00 GMT The national model links pelvic pain, perimenopause and menopause support through existing multidisciplinary services. A new femtech framework asks who innovation actually reaches https://insideher.org/news/femtech-equity-framework.html https://insideher.org/news/femtech-equity-framework.html Tue, 19 May 2026 06:00:00 GMT The proposed model puts access, regulation, representation and health-system fit alongside product growth. WHO adds an AI route to sexual and reproductive health guidance https://insideher.org/news/who-ai-tool-sexual-reproductive-health.html https://insideher.org/news/who-ai-tool-sexual-reproductive-health.html Fri, 24 Apr 2026 06:00:00 GMT The tool is part of a wider digital-innovation program intended to make trusted SRHR guidance easier to find and use.